Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Green Tea Extract,Hyaluronic Acid,Vitamin B12
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pervistop (Epigallocatechin Gallate) once-daily supplement provides a true alternative to eradicating the root problem of HPV persistence, which can unpredictably evolve into cancer.
Product Name : Pervistop
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 11, 2022
Lead Product(s) : Green Tea Extract,Hyaluronic Acid,Vitamin B12
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B12
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Fairhaven Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Oxidative Stress In Semen And Male Infertility
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 14, 2018
Lead Product(s) : Vitamin B12
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Fairhaven Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B12
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II/ Phase III
Sponsor : Tribhuvan University Teaching Hospital, Institute of Medicine | NORCE Norwegian Research Centre AS | Sykehuset Innlandet HF
Deal Size : Inapplicable
Deal Type : Inapplicable
Vitamin B12 Supplementation During Pregnancy on Cognitive Development
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 07, 2017
Lead Product(s) : Vitamin B12
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II/ Phase III
Sponsor : Tribhuvan University Teaching Hospital, Institute of Medicine | NORCE Norwegian Research Centre AS | Sykehuset Innlandet HF
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B12
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase II/ Phase III
Sponsor : Tribhuvan University, Nepal | NORCE Norwegian Research Centre AS
Deal Size : Inapplicable
Deal Type : Inapplicable
Vitamin B12, Neurodevelopment and Growth in Nepal
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
October 23, 2014
Lead Product(s) : Vitamin B12
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase II/ Phase III
Sponsor : Tribhuvan University, Nepal | NORCE Norwegian Research Centre AS
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B12
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Staten Island University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 13, 2013
Lead Product(s) : Vitamin B12
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Staten Island University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B12
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : University of Basel | Aarelab
Deal Size : Inapplicable
Deal Type : Inapplicable
Vitamin B12 Acceptance and Biomarker Response Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 15, 2013
Lead Product(s) : Vitamin B12
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : University of Basel | Aarelab
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B12
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Cyanocobalamin (Eligen B12) Bioavailability Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 09, 2011
Lead Product(s) : Vitamin B12
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B12
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 01, 2011
Lead Product(s) : Vitamin B12
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable